The Wuhan Institute of Virology announced on February 4, 2020 that they applied for a Chinese patent on Gilead’s Remdesivir for treating the novel coronavirus (2019-nCoV) that originated in Wuhan in late 2019. The Chinese patent application was filed on January 21, 2020 and the Institute plans to file internationally via the Patent Cooperation Treaty.
The China National Intellectual Property Administration (CNIPA) will no longer issue paper patent certificates for patents with authorization notices dated March 3, 2020 or later. Instead, CNIPA will issue electronic certificates through their online system. Patentees can still request paper certificates through the online system if needed though per Announcement 349 of CNIPA.
The China National Intellectual Property Administration (“CNIPA”) formally announced on December 31, 2019 the newly amended Patent Examination Guidelines (“the Guidelines”) will come into effect on February 1, 2020. The Guidelines were amended to clarify eligible subject matter in patent applications involving artificial intelligence and other new industries.
The General Office of the State Council announced that the Chinese New Year Holiday will be officially extended through and including February 2, 2020. Accordingly, the China National Intellectual Property Administration will remain closed through February 2 and reopen on February 3. Therefore, all patent and trademark deadlines falling on January 31 and February 1, 2020 will be extended to February 3, 2020. The General Office of the State Council explained that extended holiday was “to strengthen the prevention and …